- en: <!--yml
  id: totrans-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-1
  prefs: []
  type: TYPE_NORMAL
  zh: 类别：未分类
- en: 'date: 2024-05-18 17:06:20'
  id: totrans-2
  prefs: []
  type: TYPE_NORMAL
  zh: 日期：2024-05-18 17:06:20
- en: -->
  id: totrans-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: 'VIX and More: VVUS Implied Volatility Tops 700'
  id: totrans-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: VIX and More：VVUS隐含波动率超过700
- en: 来源：[http://vixandmore.blogspot.com/2010/07/vvus-implied-volatility-tops-700.html#0001-01-01](http://vixandmore.blogspot.com/2010/07/vvus-implied-volatility-tops-700.html#0001-01-01)
  id: totrans-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[http://vixandmore.blogspot.com/2010/07/vvus-implied-volatility-tops-700.html#0001-01-01](http://vixandmore.blogspot.com/2010/07/vvus-implied-volatility-tops-700.html#0001-01-01)
- en: From time to time I have highlighted extremely high [implied volatility](http://vixandmore.blogspot.com/search/label/implied%20volatility)
    in individual securities such as [FAS](http://vixandmore.blogspot.com/search/label/FAS),
    [IOC](http://vixandmore.blogspot.com/search/label/IOC), [EWZ](http://vixandmore.blogspot.com/search/label/EWZ)
    and the banks that were subject to the stress tests (see links below.)
  id: totrans-6
  prefs: []
  type: TYPE_NORMAL
  zh: 有时我会突出显示个别证券的极高[隐含波动率](http://vixandmore.blogspot.com/search/label/implied%20volatility)，例如[FAS](http://vixandmore.blogspot.com/search/label/FAS)，[IOC](http://vixandmore.blogspot.com/search/label/IOC)，[EWZ](http://vixandmore.blogspot.com/search/label/EWZ)以及受到压力测试的银行（参见下面的链接）。
- en: With the recent action in Vivus ([VVUS](http://vixandmore.blogspot.com/search/label/VVUS)),
    however, it may be time to reconsider just how extreme implied volatility can
    get. Vivus has a new weight-loss pill, Qnexa, that is under review by the FDA,
    with an FDA panel decision expected Thursday. For those who are interested in
    the details, Business Week provides a handy summary of the situation in [Vivus’s
    Diet Pill Qnexa Faces FDA Scrutiny on Safety](http://www.businessweek.com/news/2010-07-13/vivus-s-diet-pill-qnexa-faces-fda-scrutiny-on-safety.html).
  id: totrans-7
  prefs: []
  type: TYPE_NORMAL
  zh: 然而，随着Vivus（[VVUS](http://vixandmore.blogspot.com/search/label/VVUS)）最近的动态，现在可能是重新考虑隐含波动率可以达到多高的时候了。Vivus有一种新的减肥药，Qnexa，正在接受FDA的审查，预计FDA小组将在星期四做出决定。对于那些对细节感兴趣的人，Business
    Week在[Vivus的减肥药Qnexa在安全性上面临FDA审查](http://www.businessweek.com/news/2010-07-13/vivus-s-diet-pill-qnexa-faces-fda-scrutiny-on-safety.html)提供了该情况的便利摘要。
- en: In the chart below, the red line is the aggregate implied volatility of July
    options in VVUS, as calculated by [Livevol Pro](http://www.livevol.com/livevol_pro.html).
    The yellow line is August aggregate IV and the green line is September aggregate
    IV.
  id: totrans-8
  prefs: []
  type: TYPE_NORMAL
  zh: 在下面的图表中，红线是VVUS七月期权的总体隐含波动率，由[Livevol Pro](http://www.livevol.com/livevol_pro.html)计算得出。黄线是八月的总体IV，绿线是九月的总体IV。
- en: Once the FDA decision has been announced, I will be back to analyze the impact
    of the news on the various Vivus options and their implied volatility.
  id: totrans-9
  prefs: []
  type: TYPE_NORMAL
  zh: 一旦FDA的决定宣布，我将回来分析新闻对各种Vivus期权及其隐含波动率的影响。
- en: With IV this high, VVUS is probably more appropriate for spectators than investors
    right now. This is a lottery ticket – and an expensive one. Not a place for ‘risk
    capital’ in my book, but perhaps an appropriate use of ‘entertainment capital’
    if anyone one has some of that sitting around.
  id: totrans-10
  prefs: []
  type: TYPE_NORMAL
  zh: 拥有如此高的隐含波动率，VVUS现在可能更适合观众而不是投资者。这是一张彩票，而且是一张昂贵的彩票。在我看来，这不是‘风险资本’的场所，但也许是一些人有闲置资金的‘娱乐资本’的合适用途。
- en: '...unless you can find an aribitrage opportunity like Ophir Gottlieb of Livevol
    did yesterday in [Vivus (VVUS) -- Biotech''s Gigantic Vol Yields Arbs on the Table
    Right Now](http://livevol.blogspot.com/2010/07/vvus.html).'
  id: totrans-11
  prefs: []
  type: TYPE_NORMAL
  zh: '...除非你能像Livevol的Ophir Gottlieb昨天在[Vivus（VVUS）-- 生物技术的巨大波动率为目前的套利机会](http://livevol.blogspot.com/2010/07/vvus.html)中所做的那样找到套利机会。'
- en: 'For more on related subjects, readers are encouraged to check out:'
  id: totrans-12
  prefs: []
  type: TYPE_NORMAL
  zh: 更多相关主题，鼓励读者查看：
- en: '*[source: Livevol Pro]*'
  id: totrans-13
  prefs: []
  type: TYPE_NORMAL
  zh: '*[来源：Livevol Pro]*'
- en: '***Disclosure(s):*** *long VVUS at time of writing;* *Livevol* is an advertiser
    on VIX and More'
  id: totrans-14
  prefs: []
  type: TYPE_NORMAL
  zh: '***披露：*** *写作时持有VVUS的多头；* *Livevol* 是 VIX and More 的广告商'
